Pfizer Inc.
Pfizer Inc. (PFE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PFE · as of Jun 8, 2026
Key Statistics
Explore Pfizer Inc. Data
pfe stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 39 · Buy rate: 41.0%
The PFE analyst consensus is Hold, based on ratings from 39 Wall Street analysts over the past 3 months. The average 12-month price target is $27.00, representing +3.71% upside from the current price of $26.04.
Competitors & Peers
pfe competitorsPFE
AMGN
BMY
BSX
DHR
GILDStock Performance
Full HistoryAbout Pfizer Inc.
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovasc…
what is pfizer inc. · pfe stock overview · pfizer inc. company profile · who is pfizer inc. ceo · pfe NYSE · pfizer inc. headquarters · pfizer inc. business segments
About Stock Overview & Key Data
Pfizer Inc. (PFE) is a Healthcare company in the Drug Manufacturers - General industry, listed on NYSE since Jun 1, 1972. As of the latest trading session, PFE stock price is $26.04, with a market capitalization of $148.4B. The stock has returned +8.61% over the past 12 months and +4.56% year-to-date.
According to 39 Wall Street analysts, the consensus rating for Pfizer Inc. stock is Hold, with an average 12-month price target of $27.00. In fiscal year 2025, Pfizer Inc. reported revenue of $62.6B and net income of $7.8B. For detailed data — including Pfizer Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Pfizer Inc. (PFE) stock price is $26.04. The stock is traded on NYSE under the ticker symbol PFE. The 52-week range is $23.08 – $28.75.